Zoetis

-4.93%

Zoetis is a global animal health company that focuses on developing and providing medicines, vaccines, diagnostics, and other products and services to veterinarians and livestock producers. The company was formed in 2013 as a spin-off from the pharmaceutical company Pfizer, and it is headquartered in Parsippany, New Jersey.
Zoetis operates in more than 100 countries and has a diverse portfolio of products for both companion animals and livestock. Their products are used to prevent and treat diseases, improve animal welfare, and increase productivity in the livestock industry.
The company's mission is to continuously innovate and invest in new solutions for the health of animals, and its vision is to be the world leader in animal health. Zoetis also places a strong emphasis on sustainability and environmental responsibility, working to reduce its environmental impact and promote the well-being of animals, people, and the planet.
In addition to providing products and services, Zoetis is also involved in research and development, partnerships with veterinarians and farmers, and education and advocacy for animal health issues. The company has a team of more than 9,000 employees worldwide, including veterinarians, scientists, and other experts in animal health.
Zoetis has a strong commitment to corporate social responsibility, with a focus on four main areas: animal health and welfare, employee wellness and development, environmental sustainability, and the communities in which they operate. The company supports various nonprofit organizations and initiatives related to animal health and sustainability, and also has a volunteer program that encourages employees to give back to their communities.
Overall, Zoetis is a leading company in the animal health industry, dedicated to improving the health and well-being of animals through innovative products and services.

1. Global Leader in Animal Health: Zoetis is the world's largest animal health company, dedicated to developing innovative and effective solutions for the health and wellbeing of animals.
2. Wide Range of Products: The company offers a diverse portfolio of animal health products, including medicines, vaccines, diagnostics, and genetic tests, covering a wide range of species such as dogs, cats, cattle, horses, poultry, and fish.
3. Focus on Innovation: Zoetis is committed to continuously researching and developing new products and solutions to meet the evolving needs of animal healthcare.
4. Strong Presence in Emerging Markets: Zoetis has a strong presence in emerging markets, providing vital animal health solutions to support the growing demand for protein and improve the health and productivity of animals.
5. Commitment to Sustainability: The company has a sustainability framework that focuses on addressing the health of animals, people, and the planet. This includes promoting animal welfare, reducing the environmental impact of their operations, and supporting communities.
6. Collaborative Partnerships: Zoetis partners with leading universities, research institutions, and government agencies to drive innovation and advance animal health globally.
7. Veterinary Support and Educational Resources: The company provides resources and support to veterinarians to help them provide the best care for animals, including educational events, research updates, and diagnostic tools.
8. Strong Financial Performance: Zoetis has a strong financial performance, with consistent growth in revenue and earnings, demonstrating its stable position in the animal health industry.
9. Commitment to Diversity and Inclusion: Zoetis is committed to promoting diversity and inclusion in the workplace, with a focus on creating a culture of respect and equal opportunity for all employees.
10. Corporate Social Responsibility: The company is committed to making a positive impact in the communities where they operate through various CSR initiatives, including supporting animal shelters, disaster relief efforts, and youth education programs.

Zoetis is a global animal health company that is focused on discovering, developing, manufacturing, and commercializing veterinary medicines and vaccines for livestock and companion animals. The company's business model is to support customers and the overall animal health industry by providing innovative and high-quality products and services that improve the health and well-being of animals.
Zoetis generates revenue through the sale of its products, which include pharmaceuticals, vaccines, diagnostics, genetic tests, and software solutions. The company markets its products through both direct sales to veterinarians and indirect sales through distributors and resellers. Zoetis also offers services such as education and training programs, as well as technical and customer support.
In addition to its product offerings, Zoetis also engages in research and development to discover and develop new animal health solutions. The company invests heavily in clinical trials and collaborations with academic and industry partners to bring new products to market.
Another important aspect of Zoetis' business model is its commitment to sustainability and responsible animal care. The company has various initiatives and programs in place to ensure ethical and sustainable practices in all aspects of its business, from manufacturing to employee policies.
Overall, Zoetis aims to be a leader in the animal health industry by continuously improving its products and services, investing in research and development, and upholding its values of innovation, collaboration, and ethical practices.

1. Zoetis was originally a subsidiary of Pfizer, one of the world’s largest pharmaceutical companies. In 2012, it became an independent company through an initial public offering.
2. The name Zoetis is derived from the Greek word zoetic, meaning “pertaining to life.”
3. The company is the largest producer of medicine and vaccinations for pets and livestock in the world.
4. Zoetis has a presence in over 100 countries and has approximately 10,000 employees globally.
5. In 2019, Zoetis was named one of Fortune magazine’s World’s Most Admired Companies in the pharmaceutical industry for the fifth consecutive year.
6. The company invests heavily in research and development and has over 900 scientists and technical experts working to develop new treatments and tools for animal health.
7. Zoetis is committed to sustainability and has set goals to reduce its environmental impact by 2020, including reducing its greenhouse gas emissions and water usage.
8. The company also has a philanthropy program, Zoetis for Shelters, which provides medicine, vaccines, and healthcare education to animal shelters and rescue organizations worldwide.
9. In 2020, in response to the COVID-19 pandemic, Zoetis announced a $1 million donation to support frontline organizations and communities, as well as veterinary schools and animal welfare organizations.
10. One of Zoetis’ most well-known products is Rimadyl, a non-steroidal anti-inflammatory drug (NSAID) for dogs that helps with pain and inflammation. It was the first animal health product to reach $1 billion in sales.
See Company Due Diligence: